Sort
82,697 grants matching “vaccine development”
Genetic analysis of toxinogenesis of Vibrio cholerae
$847,498John J Mekalanos · Harvard Medical School · R37 · FY2020 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2023 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2022 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2021 · AI
Development of vaccination strategies to elicit broadly protective immunity against influenza
$847,458Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2020 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$847,447Johns Hopkins University · U01 · FY2002 · AI
HBV cccDNA and integrated DNA in HIV coinfection and HBV monoinfection
$847,428Daryl T Lau · Beth Israel Deaconess Medical Center · R56 · FY2023 · AI
Immune Control and Evasion during Acute HCV Infection
$847,330Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2013 · AI
Live Attenuated Bacterial Vaccines Against Plaque
$847,309James P. Nataro · University Of Maryland Baltimore · U01 · FY2009 · AI
NIH Director's Pioneer Award
$847,291Evgeny Nudler · New York University School Of Medicine · DP1 · FY2008 · OD
Human Respiratory Syncytial Virus Biology And Vaccine Development
$847,282Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Protective Immunity
$847,269David I Watkins · University Of Miami School Of Medicine · P01 · FY2014 · AI
Nonhuman Primate
$847,213Michael K Axthelm · Oregon Health & Science University · P01 · FY2011 · AI
Understanding Unconventional CD8+ T cell Responses in Protection from HIV
$847,205Jonah B. Sacha · Oregon Health & Science University · R01 · FY2018 · AI
Center for the Study of Innate Immunity to HCV Infection
$847,117Michael J Gale · University Of Washington · U19 · FY2011 · AI
NKT cells as modulators of AIDS vaccine efficacy
$846,896Amitinder Kaur · Harvard Medical School · R01 · FY2012 · AI
Optimizing the graft versus leukemia effect for pediatric ALL
$846,887Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
$846,776Charles M. Rice · Rockefeller University · R01 · FY2024 · AI
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
$846,776Charles M. Rice · Rockefeller University · R01 · FY2025 · AI
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
$846,776Charles M. Rice · Rockefeller University · R01 · FY2023 · AI
Signal Transduction Events and the Regulation of Cell Growth
$846,744Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2015 · CA
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$846,737Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
Center for serological testing to improve outcomes from pandemic COVID-19 (STOP-COVID)
$846,715Eugene M. Oltz · Ohio State University · U54 · FY2024 · CA
Development of highly neutralizing nanobodies against HIV-1, SARS-CoV-2 and other pathogens
$846,518Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2022 · AR
Diabetes Evaluation in Washington (DEW-IT) Clinical Cen*
$846,500William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2007 · DK